{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-GROWTH/4579",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# RaQualia Pharma Inc. (Growth Market: 4579) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is RaQualia Pharma Inc., listed on the Growth Market under ticker 4579. The ISIN is not on the record. The LEI is not on the record. The security type is Corporate. The segment is not on the record. The sector is 3250 Pharmaceutical. The jurisdiction is Japan (EDINET domestic filer). The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 8 filings in the twelve months to 2026-11-06, across 5 filing days. The median gap between filing days is 50.5 days. The latest filing is dated 2026-08-14, a regulatory filing, 84 days before the record date. The Growth Market median cadence gap is 42 days across 598 issuers, and the median latency is 85.0 days. The 3250 Pharmaceutical median cadence gap is 49.5 days across 80 issuers, and the median latency is 85.0 days. The issuer's filings by type are 1 ad hoc, 2 prospectus, 3 regulatory filing and 2 results.\n\n## Auditor\n\nThe auditor of record is EY新日本有限責任監査法人. Its location is not on the record. The market's record does not carry auditor changes.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register. The issuer is listed and not halted.\n\n## Orderability\n\nThe outcome for Qualified Institutional Investors is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nOne research house is named on the issuer's investor-relations page: Shared Research, Inc.\n\n## Open research\n\nOne openly published research note is on the record: Shared Research Inc., dated 2022-09-09.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4579 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSQX (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.raqualia.com/en/ir/library/analyst.html (coverage)\n- https://www.raqualia.com/en/ir/library/analyst/main/01/teaserItems3/0/linkList/00/link/RaQualia_20220909_EN.pdf (open research)\n- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4579 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSQX",
    "state": "sourced",
    "value": "EY新日本有限責任監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-GROWTH/4579",
  "coverage": {
   "count": 1,
   "houses": [
    {
     "house": "Shared Research, Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "since": "2022-09-09",
     "source": "https://www.raqualia.com/en/ir/library/analyst.html",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.raqualia.com/en/ir/library/analyst.html",
     "result": "read: 1 of 2 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "stated per house where the page states it",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 598,
     "median_cadence_gap_days": 42,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "Growth Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "prospectus": 2,
    "regulatory_filing": 3,
    "results": 2
   },
   "cadence_median_gap_days": 50.5,
   "filing_days": 5,
   "filings": 8,
   "latency_days": 84,
   "latest": [
    {
     "category": "135",
     "date": "2026-08-14",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YWYC",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "半期報告書 (half-year report)",
     "date": "2026-08-14",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YWY3",
     "title": "半期報告書－第19期(2026/01/01－2026/12/31)",
     "type": "results"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-03-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XUZ6",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "有価証券報告書 (annual securities report)",
     "date": "2026-03-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSQX",
     "title": "有価証券報告書－第18期(2025/01/01－2025/12/31)",
     "type": "results"
    },
    {
     "category": "235",
     "date": "2026-03-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSQW",
     "title": "内部統制報告書－第18期(2025/01/01－2025/12/31)",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-08-14",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4579",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Growth Market"
   },
   "isin": {
    "market": "JP",
    "reason": "no LEI, so no GLEIF ISIN route",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "market": "JP",
    "reason": "no GLEIF record registered as 1800-01-095399 (RA000412)",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "RaQualia Pharma Inc."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4579"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:1f8c9d5e97c059b3f2ad6fac953329fa4e9d6185e25ad7d0afd55365fdd3c705",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2022-09-09",
     "kind": "issuer-sponsored",
     "publisher": "Shared Research Inc.",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.raqualia.com/en/ir/library/analyst/main/01/teaserItems3/0/linkList/00/link/RaQualia_20220909_EN.pdf",
     "state": "sourced",
     "title": "Research Coverage Report by Shared Research Inc."
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4579",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:1f8c9d5e97c059b3f2ad6fac953329fa4e9d6185e25ad7d0afd55365fdd3c705",
 "path": "/jp/TSE-GROWTH/4579",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is RaQualia Pharma Inc., listed on the Growth Market under ticker 4579. The ISIN is not on the record. The LEI is not on the record. The security type is Corporate. The segment is not on the record. The sector is 3250 Pharmaceutical. The jurisdiction is Japan (EDINET domestic filer). The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 8 filings in the twelve months to 2026-11-06, across 5 filing days. The median gap between filing days is 50.5 days. The latest filing is dated 2026-08-14, a regulatory filing, 84 days before the record date. The Growth Market median cadence gap is 42 days across 598 issuers, and the median latency is 85.0 days. The 3250 Pharmaceutical median cadence gap is 49.5 days across 80 issuers, and the median latency is 85.0 days. The issuer's filings by type are 1 ad hoc, 2 prospectus, 3 regulatory filing and 2 results.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is EY新日本有限責任監査法人. Its location is not on the record. The market's record does not carry auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome for Qualified Institutional Investors is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "One research house is named on the issuer's investor-relations page: Shared Research, Inc.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "One openly published research note is on the record: Shared Research Inc., dated 2022-09-09.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4579"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSQX"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.raqualia.com/en/ir/library/analyst.html"
  },
  {
   "for": "open research",
   "source": "https://www.raqualia.com/en/ir/library/analyst/main/01/teaserItems3/0/linkList/00/link/RaQualia_20220909_EN.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4579"
  }
 ],
 "title": "RaQualia Pharma Inc. (4579) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}